Expert Teaches on Colorectal Cancer Screening and Surveillance

OSU Wexner Medical Center logo Expert Teaches on Colorectal Cancer Screening and Surveillance. For this topic, we’ve invited a national leader on polyp surveillance. Dr. Peter Stanich is an Associate Professor of Internal Medicine at Ohio State University specializing in Gastroenterology. He is director of Intestinal Neoplasia and Hereditary Polyposis at Ohio State and the immediate past president of the national society: Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand current recommendation for age to start screening in average risk and increased risk patients.
  • Be aware of recommended surveillance colonoscopy intervals based on colonoscopy findings.

You’ll also learn about the following:

  • Advanced Adenomas
  • Red Flags
  • Adenoma Detection Rate
  • High Risk Patient

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest About Prostate Cancer Screening on CME Webcast

OSU Wexner Medical Center logo Learn Latest About Prostate Cancer Screening on CME Webcast. Practicing here in the United States, 1 out of every 8 men will have prostate cancer. Prostate cancer is deadly too. It is the 2nd most common cause of cancer death in men after lung cancer. So, clinicians need to know when and how to screen for this very common form of cancer. To teach us about this important topic, We’ve invited one of Ohio State University James Cancer Hospital’s Urologic oncology experts. We’re pleased to introduce Assistant Professor of Urology Dr Shawn Dason.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the rationale, benefits, and harms of prostate cancer screening.
  • Have an approach for prostate cancer screening in a primary care setting

You’ll also learn about the following:

  • False Positives
  • Sensitivity
  • Frequency of screening
  • Types of Screening
  • Prevention

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Pancreatic Cancer

OSUWexnerbloglogo2014 CME Webcasts Teaches on Pancreatic Cancer. It wasn’t until the 20th century that histopathologic diagnosis confirmed pancreatic adenocarcinoma. Pancreatic cancer still remains one of the most lethal cancers today. So we’re excited to have two of Ohio State University James Cancer Hospital’s cancer experts here to discuss pancreatic cancer. First, we have Dr Aslam Ejaz who is a surgical oncologist specializing in Hepato-Pancreato-Biliary and Gastrointestinal cancer surgeries. Second, we have Dr Arjun Mittra, who is a medical oncologist specializing in gastrointestinal cancers. Together they work in a multidisciplinary team to provide care to patients gastrointestinal cancers including pancreatic cancer.

What you’ll learn in this webcast

  • As a result of this educational activity, webcast participants will be able to:
  • Provide an overview of the workup and diagnosis of patients with suspected pancreatic cancer.
  • Provide an overview of treatment strategies based on the stage of disease.
  • Review common presentations and appropriate workup for patients with suspected pancreatic cancer.
  • Discuss the multidisciplinary nature of pancreatic cancer care, with a focus on managing complications, comorbidities and supportive care.

You’ll also learn about the following:

  • Diagnosis and Treatment Updates
  • Pre-malignant Lesions

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Cancer Survivorship

OSUWexnerbloglogo2014 CME Webcast Teaches on Cancer Survivorship. Now, in addition to traditional chemotherapy, we have hormonal therapy, driver-directed cancer therapies and immunotherapy. As a result, more people are surviving cancer than ever before. But with survivorship came new medical problems. On this CME Webcast, we are going to hear about cancer survivorship and what physicians need to know in order to manage some of the medical conditions attendant to survivorship. We’re pleased to welcome today’s guest, oncologist and Assistant Professor of Internal Medicine, Dr. Ashley Pariser.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Define Cancer Survivorship and Summarize Prevalence and Characteristics of Cancer Survivors in the United States.
  • Summarize Recommendations for Recurrence Screening for Breast, Prostate, Colon and Melanoma.

You’ll also learn about the following:

  • Cancer survivorship and immunotherapy
  • Pregnancy in breast cancer survivors
  • Pharmacologic management of depression in cancer survivors
  • Anxiety management in cancer survivors
  • Diet and cancer survivorship
  • Return to work for cancer survivors

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Kidney and Bladder Cancer On Webcast

OSUWexnerbloglogo2014 Learn About Kidney and Bladder Cancer On Webcast. Today, nephrectomies are commonly performed to treat kidney cancer as well as other conditions. On this webcast, we will hear from two of Ohio State University Wexner Medical Center & James Cancer Hospital’s Urologic surgeons on the treatment of both kidney and bladder cancers. We’re delighted to introduce Assistant Professor of Urology Dr Debashish Sundi and Associate Professor of Urology Dr Geoffrey Box.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize how to evaluate hematuria, including when to refer for cystoscopy and upper urinary tract imaging; describe how bladder cancer treatments vary widely based on stage and grade; describe the treatment options for kidney cancer; and describe the appropriate radiographic evaluation of a renal mass.

You’ll also learn about the following:

  • Imaging
  • Tests prior to referral
  • Stage at diagnosis
  • Screening for kidney cancer
  • Prevention

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.